Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen
Vir Biotechnology (NASDAQ:VIR) Posts Earnings Results, Beats Expectations By $0.14 EPS - Zolmax
Vir Biotechnology Q2 Earnings Call Highlights
Vir Biotechnology Inc (VIR) (Q2 2026) Earnings Call Highlights: 88% HDV Cure Rate and a $1B ...
Vir Biotechnology (NASDAQ:VIR) Posts Quarterly Earnings Results, Beats Estimates By $0.14 EPS
Renaissance Technologies LLC Increases Stake in Vir Biotechnology, Inc. $VIR
950,000 Shares in Vir Biotechnology, Inc. $VIR Bought by Avidity Partners Management LP - Daily Political
Vir Biotechnology (VIR) Expected to Post Earnings on Wednesday
ADAR1 Capital Management LLC Invests $24.59 Million in Vir Biotechnology, Inc. $VIR
Vir Biotechnology (VIR) Expected to Announce Earnings on Wednesday - Daily Political
Eversept Partners LP Takes $2.24 Million Position in Vir Biotechnology, Inc. $VIR - Zolmax
Empyrean Capital Partners LP Invests $4.73 Million in Vir Biotechnology, Inc. $VIR
Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - What's Next? - Stock Observer
Monashee Investment Management LLC Makes New Investment in Vir Biotechnology, Inc. $VIR - Markets Daily
Monashee Investment Management LLC Takes Position in Vir Biotechnology, Inc. $VIR - Stock Observer
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - Stock Observer
Vir Biotechnology, Inc. $VIR Shares Acquired by Candriam S.C.A. - Zolmax
Vir Biotechnology, Inc. $VIR Shares Bought by Candriam S.C.A.
VirBiotechnology News
Dow Jones Forecast for 2026 and 2030: Could the Index Reach 75,000?
S&P 500 Forecast and Predictions for 2026, 2027 and 2030, Can US Stocks Find a Second Wind?
Broadcom (AVGO) Stock Forecast 2026–2030: Can AI Growth Drive Further Gains?
Latest news
Show more
Gold Price Today, August 10, 2026: Gold Holds Near $4,340 After Best Week Since January
CPI Preview: July Inflation Could Decide Whether the Fed’s Hiking Cycle Is Over
US July PPI Preview: Inflation’s Second Test Could Shake Fed Rate Bets
